RVMD - Revolution Medicines, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$159.00
DETAILS
HIGH:
$205.00
LOW:
$73.00
MEDIAN:
$163.50
CONSENSUS:
$159.00
UPSIDE:
4.91%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 315,860 | $30.7M | 0.9% | +315,860 | NEW |
| Greenblatt | 125,901 | $12.2M | 0.0% | +12,072 | INCREASED |
| Cooperman | 25,000 | $2.4M | 0.0% | -1,588,730 | DECREASED |
| Wood | 2,600 | $252,850 | 0.0% | -444,016 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-27 | Mancini Anthony | officer: See Remarks | M-Exempt | 3,120 | $33.62 | $105K |
| 2026-04-27 | Mancini Anthony | officer: See Remarks | SELL | 1,671 | $131.66 | $220K |
| 2026-04-27 | Mancini Anthony | officer: See Remarks | SELL | 1,049 | $132.88 | $139K |
| 2026-04-27 | Mancini Anthony | officer: See Remarks | SELL | 400 | $134.34 | $54K |
| 2026-04-15 | GOLDSMITH MARK A | director, officer: See Remarks | M-Exempt | 96,756 | $4.73 | $458K |
| 2026-04-15 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 120,000 | $150.09 | $18.0M |
| 2026-04-15 | GOLDSMITH MARK A | director, officer: See Remarks | M-Exempt | 23,244 | $4.09 | $95K |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | SELL | 1,800 | $93.22 | $168K |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | SELL | 3,128 | $94.16 | $295K |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | SELL | 21,086 | $95.49 | $2.0M |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | SELL | 11,036 | $96.43 | $1.1M |
| 2026-03-20 | Mancini Anthony | officer: See Remarks | ? | -- | -- | -- |
| 2026-03-20 | Sandler Alan B. | officer: Chief Development Officer | ? | 11,700 | $102.02 | $1.2M |
| 2026-03-20 | Sandler Alan B. | officer: Chief Development Officer | ? | 167,300 | $58.84 | $9.8M |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | SELL | 400 | $97.21 | $39K |
| 2026-03-20 | Mancini Anthony | officer: See Remarks | ? | 149,800 | $33.62 | $5.0M |
| 2026-03-20 | Mancini Anthony | officer: See Remarks | ? | 26,200 | $102.02 | $2.7M |
| 2026-03-20 | Sandler Alan B. | officer: Chief Development Officer | ? | -- | -- | -- |
| 2026-03-25 | Mancini Anthony | officer: See Remarks | M-Exempt | 37,450 | $33.62 | $1.3M |
| 2026-03-17 | Cislini Jeff | officer: General Counsel | SELL | 1,795 | $99.48 | $179K |
| 2026-03-19 | Cislini Jeff | officer: General Counsel | SELL | 1,163 | $97.44 | $113K |
| 2026-03-17 | Wei Lin | officer: Chief Medical Officer | SELL | 2,073 | $99.48 | $206K |
| 2026-03-17 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 12,871 | $99.48 | $1.3M |
| 2026-03-17 | Horn Margaret A | officer: Chief Operating Officer | SELL | 4,583 | $99.48 | $456K |
| 2026-03-17 | Kelsey Stephen Michael | officer: See Remarks | SELL | 4,302 | $99.48 | $428K |